News and Press Releases

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development

Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring 5 October 2023 -- California, US -- Bio-Rad Laboratories,...

Category: Drug Discovery
Posted: October 5, 2023

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers 

Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning and genotyping.  28 September 2023 -- California, US -- Bio-Rad Laboratories, a global leader in life science...

Category: Drug Discovery
Posted: September 28, 2023

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET